LONDON (Reuters) - Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial intelligence model that could drastically reduce the time and money needed to ...

Enchant provides Iambic’s scientists a new in silico tool to reduce clinical risk by predicting the viability of molecules from the earliest stage of drug discovery programs. These predictions ...